Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kenji Ishimaru is active.

Publication


Featured researches published by Kenji Ishimaru.


Cytotechnology | 1990

High density culture of hybridoma cells using a perfusion culture vessel with an external centrifuge.

Michiyuki Tokashiki; Takami Arai; Kimihiko Hamamoto; Kenji Ishimaru

The influence of centrifugal force on the growth of cells was examined by exposing the cells of the mouse-human hybridoma X87 line to centrifugal force (100–500 G) for ten minutes twice a day and comparing the static culture with that of unexposed cells. In this experiment, both cell proliferation and specific antibody productivity were independent of the centrifugal effect, and gave the same results as in the case of no exposure to centrifugal force. High density cultivation of the mouse-human hybridoma X87 line was obtained by a perfusion system where the cells were separated from the culture medium by continuous centrifugation. In the serum-free culture, the maximum viable cell density exceeded 107 cells/ml, and monoclonal antibody was stably produced for 37 days. The results in this culture were equivalent to those obtained by intermittent centrifugal cell separation from the culture medium, and separation by gravitational settlement.


Archive | 1995

Large Scale Suspension Perfusion Culture Process with a Compact Centrifuge for Mammalian Cell Recycle

Seiichi Yokoyama; Hiroyuki Takamatsu; Kimihiko Hamamoto; Masamichi Motoki; Takami Arai; Kenji Ishimaru; Masahiro Kimura; Akira Tanokura; Shoji Ono; Kenji Nagura; Michiyuki Tokashiki

We have established an industrially competitive and original suspension perfusion culture process meeting the commercial production of pharmaceuticals. The system basically consists of usual culture vessel with an agitator and a compact external centrifuge for cell recycle, which facilitates expansion of production with scale-up potential highly increased. The cells separated in the centrifuge can be withdrawn easily from the centrifuge as the cells are kept viable and the system can continuously work for a long period of time with no cell clogging by feeding a liquid carrier such as perfluorocarbon into the centrifuge and pushing the cells out with the liquid carrier. Further, it can be widely applied not only to anchorage-independent hybridoma cells but also to 293 cells which are intrinsically anchorage-dependent cells but have been allowed to adapt to the suspension culture. These have been veri lied by the following results: I) Maximum separation capacity of the centrifuge attained so far is about 1.6 Umin at 100 G in hybridoma cells and large scale-up can be expected, 2) long operated-Umin at 100 G in hybridoma cells and large scale-up can be expected, 2) long operated-perfusion culture of about 4 months has been performed at (1-2)x107 cells/ml with hybridoma cens, 3) perfusion culture of 293 cells producing recombinant Protein C has maintained (1-2)x107 cells/ml over 2 months.


Archive | 1982

Vitamin D3 derivatives, process for preparation thereof, and antigens comprising said derivatives to be used for preparation of antibodies for immunochemical assay and antibodies prepared therefrom

Junichi Oshida; Osamu Nishikawa; Hideki Tsuruta; Toru Takeshita; Itaru Yamamoto; Kenji Ishimaru


Archive | 1987

Culture apparatus and method

Kimihiko Hamamoto; Michiyuki Tokashiki; Yataro Ichikawa; Takami Arai; Kenji Ishimaru


Archive | 1982

Process for the preparation of active-type vitamin D3 compounds

Osamu Nishikawa; Kenji Ishimaru; Toru Takeshita; Hideki Tsuruta


Archive | 1980

25-Hydroxy-24-oxocholestane derivatives and preparation thereof

Osamu Nishikawa; Kenji Ishimaru; Toru Takeshita; Hideki Tsuruta


Archive | 1990

Centrifugal separator, method of separating animal cells from animal cell-containing suspension using said centrifugal separator, and method of culturing animal cells in suspension using said centrifugal separator

Michiyuki Tokashiki; Kimihiko Hamamoto; Kenji Ishimaru


Archive | 1983

25-hydroxyvitamin d3-26,23-lactone derivative and its preparation

Kenji Ishimaru; Junichi Oshida; Hideki Tsuruta


Archive | 1981

Novel vitamin d3 derivative and its preparation

Kenji Ishimaru; Junichi Oshida; Hideki Tsuruta


Archive | 1987

Method for treating synthetic pulp particles, and pulp particles composed of synthetic polymer

Michio Yamamoto; Tsutomu Kiriyama; Noriaki Sasaki; Yoshitaka Sakamoto; Kenji Ishimaru

Collaboration


Dive into the Kenji Ishimaru's collaboration.

Researchain Logo
Decentralizing Knowledge